Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal Melanoma
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this clinical research study is to learn if pre-operative radiation therapy after starting immune checkpoint inhibition can help patients with sinonasal or anorectal melanoma have better outcomes
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony nowotwór błony śluzowej w badaniu lub na zdjęciach
- •Brak przerzutów do innych części ciała
- •Planiowana immunoterapia kombinowana (np. ipilimumab z nivolumabem)
- •Wiek co najmniej 18 lat
- •Ogólna kondycja pacjenta wystarczająca do leczenia
✗ Disqualifies
- •Ciąża lub karmienie piersią
- •Brak możliwości zastosowania odpowiedniej antykoncepcji w trakcie badania
- •Wiek poniżej 18 lat
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 10, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
M D Anderson Cancer Center
Houston, United States
Trial contact
Devarati Mitra, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/11/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.